Fundraising Fox
Moncef Slaoui
InvestorVenture Partner at Medicxi · Board director at Altesa BioSciences
Philadelphia, Miami
Find your path to Moncef
46 people in our graph can introduce you to Moncef.
Each arrow is one introduction. Sign up to fill in the first one.
Ask John Clerici to introduce you to Moncef
You →John · together at Altesa BioSciences →Moncef
Ask Jamie Chen to introduce you to Moncef
You →Jamie · 11 people · together at Medicxi →Moncef
Sign up to find every way you can get introduced to Moncef
- Your email: the people you already email who know Moncef
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Moncef
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Venture Partner at Medicxi supporting portfolio companies such as Curevo and Altesa Biosciences (and previously ViceBio, acquired by Sanofi). He formerly served as Chief Scientific Advisor to Operation Warp Speed and spent nearly 30 years at GlaxoSmithKline in senior R&D and vaccines leadership roles. He holds a PhD in Molecular Biology and Immunology from the Universite Libre de Bruxelles and has served on numerous biotech boards including Moderna, Vaxcyte, Arcturus Therapeutics and Zephyr AI.
Invests in
BiotechHealthtechMedical Devices
Board director at Altesa BioSciences
Intro paths
In turn, Moncef can intro founders to Altesa BioSciences's investors below.
Deals · 3
Altesa BioSciencesBoard seat
via Medicxi · filed Feb 2026 · $75M raise
SUTROVAX, INC.Board seat
via Medicxi · filed Apr 2020 · $110M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Arcturus TherapeuticsCurevoGalvaniLonza Group AGModerna, Inc.Vaxcyte
Investor
CurevoVicebio
Sources: SEC Form D filings · the firm's website.
Colleagues at Medicxi
Frequently asked questions
- Who is Moncef Slaoui?
- Venture Partner at Medicxi supporting portfolio companies such as Curevo and Altesa Biosciences (and previously ViceBio, acquired by Sanofi). He formerly served as Chief Scientific Advisor to Operation Warp Speed and spent nearly 30 years at GlaxoSmithKline in senior R&D and vaccines leadership roles. He holds a PhD in Molecular Biology and Immunology from the Universite Libre de Bruxelles and has served on numerous biotech boards including Moderna, Vaxcyte, Arcturus Therapeutics and Zephyr AI.
- Where does Moncef Slaoui work?
- Moncef Slaoui is Venture Partner at Medicxi and Board director at Altesa BioSciences.
- What does Moncef Slaoui invest in?
- Moncef Slaoui invests in Biotech, Healthtech, Medical Devices.
- What boards does Moncef Slaoui sit on?
- Moncef Slaoui holds tracked board seats at Altesa BioSciences, Arcturus Therapeutics, Curevo, Galvani, Lonza Group AG, Moderna, Inc., SUTROVAX, INC., Vaxcyte, Zephyr AI.
- What companies has Moncef Slaoui invested in?
- Investments tracked here include Altesa Biosciences, Curevo, Vicebio.